Firm warns pro­posed generic drug changes could hurt them

The Guardian (Charlottetown) - - BUSINESS -

MON­TREAL — Que­bec phar­macy leader Jean Coutu posted im­proved third-quar­ter prof­its on Thurs­day but warned that could change in the fu­ture if the provin­cial gov­ern­ment con­tin­ues to look for sav­ings by tin­ker­ing with the drug dis­tri­bu­tion sys­tem. Chief ex­ec­u­tive Fran­cois Coutu de­scribed the re­la­tion­ship be­tween the in­dus­try and the prov­ince as “un­pre­dictable,” making it dif­fi­cult to fully an­tic­i­pate the im­pact on its oper­a­tions. Specif­i­cally, the com­pany crit­i­cized the prov­ince’s pro­posal to sus­pend for at least three years the 15 per cent cap on fees paid to phar­ma­cist own­ers by generic drug man­u­fac­tur­ers like Jean Coutu’s Pro Doc sub­sidiary.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.